Latest Development Program News

Delta Lithium reported a $13.2 million FY2026 profit after separating its gold assets into Ballard Mining, while advancing lithium projects at Mt Ida and Yinnetharra. The result was supported heavily by demerger-related accounting gains, leaving the next test firmly operational: whether the projects can move towards production.

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Innovaero Technologies is seeking A$40 million through a proposed ASX listing to advance its OWL loitering munition program and expand manufacturing capacity. The replacement prospectus also makes clear that the company remains loss-making and heavily dependent on the Department of Defence converting development work into production orders.

Chariot Resources has secured A$1.1 million from institutional and sophisticated investors to advance its proposed Nigerian lithium acquisition, exploration and partner-funded development program. The raising also brings potential option dilution and only partially addresses the company’s secured debt.

Ceretas has completed the third milestone of its government-backed CUREator+ program, unlocking a final $692,578 non-dilutive funding tranche. The work delivered functional prototypes of proprietary neuronavigation software and a lift assist device intended to simplify operation of its next-generation Alzheimer’s ultrasound system.

Prescient Therapeutics has extended its Share Purchase Plan by three days after shareholders reported delays receiving application documents. The revised timetable places the offer’s results announcement just ahead of a planned briefing on the company’s PTX-100 development program.

Red Sky Energy has started drilling Yarrow 5 in South Australia, the second well in a three-well development program operated by Santos. The well is expected to reach 2,775 metres by 14 September, with a further re-entry planned before first gas from Yarrow North 1 is targeted for early 2027.

Emyria has reported a sharp increase in FY26 revenue while expanding its psychedelic-assisted therapy network to five operational or announced clinics and 18 beds. Its first Sydney clinic is now fitted out and scheduled to begin treating patients in September, but utilisation and funding remain the next tests.

Impact Minerals’ 50%-owned Alluminous project reveals a strong financial case for a staged US high purity alumina plant, projecting a post-tax NPV₈ of A$518 million and a 42.3% IRR under a modular development approach.

Phoslock Environmental Technologies has advanced a new range of lanthanum-enhanced phosphorus-binding products showing up to four times the capacity of current offerings, with pilot and manufacturing tests confirming strong performance and low lanthanum release. Field trials are underway, aiming for commercial sales in 2027.

Stonehorse Energy has sold its US Lone Star oil and gas interests for US$1.114 million, shifting focus to expanding its Drumheller development program in Alberta.

Brookside Energy has expanded its US production base by acquiring Lone Star’s oil and gas interests, adding 123 BOEPD of low-decline, cash-flowing assets without issuing new equity.